ACR supports patients' access to treatments act of 2013

February 12, 2013
ACR supports patients' access to treatments act of 2013
The American College of Rheumatology has joined the Coalition for Accessible Treatments, in support of the Patients' Access to Treatments Act of 2013, which will reduce the out-of-pocket expenses for medications, including biologics.

(HealthDay)—The American College of Rheumatology (ACR) has joined the Coalition for Accessible Treatments, in support of the Patients' Access to Treatments Act of 2013, which will reduce the out-of-pocket expenses for medications, including biologics.

Noting that some are placing biologics in "specialty tiers," which require patients to pay 20 to 50 percent of , Rep. David B. McKinley (R-WV) and Rep. Lois Capps (D-Calif.) have reintroduced legislation to limit cost-sharing requirements for medications placed in these tiers, increasing accessibility by decreasing excessive out-of-pocket expenses.

The Patients' Access to Treatments Act of 2013 is supported by the Coalition for Accessible Treatments, which is encouraging patients and physicians to ask lawmakers to support and cosponsor the act. The American College of Rheumatology is one of 18 member organizations that have joined the coalition.

"Biologics are essential tools used to fight the progression of and prevent disability," Audrey Uknis, M.D., president of the American College of Rheumatology, said in a statement. "The ACR is encouraged that Reps. McKinley and Capps have reintroduced this important bill and continue to advocate that patients with should have access to live-saving treatments."

Explore further: No difference in death rates among patients exposed to common rheumatoid arthritis drugs

More information: More Information

Related Stories

No difference in death rates among patients exposed to common rheumatoid arthritis drugs

August 8, 2012
New research confirms no significant difference in the rates of death among patients with rheumatoid arthritis (RA) who were exposed to one of several TNF inhibitors used to treat RA, adalimumab (Humira), etanercept (Enbrel), ...

Newer, more expensive psoriasis drugs only slightly more effective than older therapies under real world conditions

April 30, 2012
More expensive biologic treatments for psoriasis were only marginally more effective than standard treatments, according to a new study led by researchers in the Perelman School of Medicine at the University of Pennsylvania. ...

ACR updates guidelines for use of DMARDs and biologic drugs in treating rheumatoid arthritis

April 2, 2012
The American College of Rheumatology (ACR) has released the 2012 recommendations for the use of disease-modifying antirheumatic drugs (DMARDs) and biologic agents in the treatment of rheumatoid arthritis (RA). The guidelines ...

American College of Rheumatology releases first classification criteria for polymyalagia rheumatica

March 2, 2012
The American College of Rheumatology has released the first classification criteria for polymyalgia rheumatica – aimed at helping physicians identify patients with this condition, which occurs in persons aged 50 years ...

ACR in Choosing Wisely campaign to promote wise use of resources among physicians and patients

December 14, 2011
As part of its ongoing efforts to ensure safe, effective and appropriate medical imaging, the American College of Radiology has joined the ABIM Foundation and eight other medical specialty societies in Choosing Wisely. The ...

Recommended for you

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.